Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
5 Patents
#26 in Leiden
#1,131 in Netherlands
Dcprime B.v.
Forward Citations = 11
9 inventors:
Dcprime B.v.
EPO Patents = 2
Trademarks = 1
Forward Citations = 11
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Adriana Maria Kruisbeek (3 out of 3 patents)
Sandra Van Wetering (3 out of 3 patents)
Erik Hans Manting (2 out of 5 patents)
4. Satwinder Kaur Singh (2 out of 5 patents)
5. Vinod Sommandas (2 out of 2 patents)
6. Rieneke Van De Ven (1 out of 5 patents)
7. Tanja Denise De Gruijl (1 out of 8 patents)
8. Adriane Marie Kruisbeek (1 out of 1 patent)
9. Riekeld Johannes Scheper (1 out of 2 patents)
10. Adriana Marie Kruisbeek (0 patent)
11. Van Sandra Wetering (0 patent)
5 patents:
Company Overview
DCprime is a clinical-stage company focused on accelerating the development of innovative cancer immunotherapies. We harness the full potential of the immune system to actively and specifically target and destroy cancer cells. With a proprietary technology platform and a strong team of experts, we aim to improve the lives of patients with cancer through the development of novel therapies.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dcprime B.v.. Retrieved from https://idiyas.com/company/dcprime-b-v
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]